Now we have to wonder how long the lesion (pre-myeloma) will sit there. We can’t pretend they’re not there, but we don’t know what they mean.
A single plasmacytoma (SBP), monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) are all NOT cancer. They are pre-myeloma. A oncologist might call them blood disorders. But they are not multiple myeloma.
The first article linked and excerpted below are about an interesting case. A really active, healthy guy who definitely has a SBP and had indications of multiple myeloma, but has not been diagnosed with full blown MM.
The article below that one discusses chemotherapy for the pre-MM patient to slow possible MM.
So what do you do?Pre-MM may become frank MM in a year or two. Or you may be able to remain in a pre-MM state for the rest of your life.
When I was first diagnosed in February of ’94 I too had a single plasmacytoma. No one ever said anything about “pre-MM.” The pre-MM cancer coaching program are those evidence-based therapies that studies have shown can reduce your risk of a full blown MM diagnosis.
There are a host of evidence-based but non-toxic therapies shown to reduce the risk of a MM diagnosis. Consider supplementation (curcumin, omega-3, green tea extract, others), anti-angiogenic nutrition, and lifestyle therapies.
ER doctor refuses to sit idly by waiting on disease to progress
“Although the break was fixed, a biopsy revealed that it was caused by a solitary plasmacytoma, a cluster of cancerous plasma cells found in a single site, usually bone..
Plasma cells are a type of white blood cell that produces antibodies. When they become abnormal, the cells are called myeloma, and when myeloma cells collect in several areas of the body, the resulting disease is called
multiple myeloma.
But Herrin doesn’t have multiple myeloma – not yet.
Herrin had radiation to treat the plasmacytoma in his arm, and a PET scan revealed small lesions on his thoracic spine, sacrum and ribs. The scan indicated that the cancer may have spread, but wasn’t conclusive enough to warrant further treatment…
“Now we have to wonder how long the lesions will sit there. We can’t pretend they’re not there, but we don’t know what they mean. The best-case scenario is that everything just sits right where it is...
But you begin to wonder what you can do instead of just waiting.”
“Smoldering multiple myeloma (SMM) is a heterogeneous clinical entity that defines patients in the spectrum of disease progression from monoclonal gammopathy of undetermined significance to multiple myeloma (MM). Current standard of care is observation until end organ damage occurs. In spite of this, the scientific community has begun to question whether the strategy of watchful waiting should be replaced with earlier therapeutic intervention with the ultimate goal of preventing clonal heterogeneity and end organ damage…
“A recent pilot study found that curcumin, in certain patients with monoclonal gammopathy of undetermined significance (MGUS), decreases the paraprotein load…”
